Crinetics (CRNX) announced that the European Medicines Agency has validated the marketing authorization application for paltusotine, the first ...

AbbVie announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib (Rinvoq; 15 mg, once ...

Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing ...

The study, which has an FDA and EMA-approved protocol, will enroll patients in Europe, with the U.S. and Canada expected to follow. The randomized, double-blind, placebo-controlled study aims to ...

JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue ® from DORC ... Administration (NMPA) approval in China, marking a ...

Traumatic Brain Injury companies include Supernus Pharmaceuticals, Inc., Hope Biosciences, The SanBio Group, Merz Pharmaceuticals GmbH, Cellvation, Inc., Abalonex ...

Upon positive conclusion of the Phase 3 program, the Company plans to submit a New Drug Application (NDA) to the U.S. FDA and Marketing Authorization Plan (MAA) to the EMA. Piclidenoson is a novel, ...

Blue Ivy Carter just gave the controversial cool girl trend her stamp of approval, and yes, we are talking about wearing sunglasses at night. Over the weekend, Blue Ivy was spotted attending the ...

Upon positive conclusion of the Phase 3 program, the Company plans to submit a New Drug Application (NDA) to the U.S. FDA and Marketing Authorization Plan (MAA) to the EMA. Piclidenoson is a novel ...

"We are delighted to bring ILM-Blue to the Chinese market, where it will provide retina surgeons with a proven, high-quality staining solution to enhance visualization," says Jessie Jiang Bo, General ...